SECsense Logo

Processa Pharmaceuticals, Inc. 8-K Report: Key Insights & Financial Overview

$PCSA
Form 8-K
Filed on: 2025-02-11
Source
Processa Pharmaceuticals, Inc. 8-K Report: Key Insights & Financial Overview

Based on the provided section of the financial report, here are the key pieces of information and insights extracted:

  1. Entity Information:
  • Company Name: Processa Pharmaceuticals, Inc.
  • CIK (Central Index Key): 0001533743
  • SEC File Number: 001-39531
  • EIN (Employer Identification Number): 45-1539785
  • Address: 7380 Coca Cola Drive Suite 106, Hanover, MD 21076
  • Contact Number: (443) 776-3133
  1. Filing Details:
  • Filing Date: February 11, 2025
  • Filing Type: 8-K (a report of unscheduled material events or corporate changes)
  1. Financial Metrics:
  • Common Stock Par Value: $0.0001
  • Stock Exchange: NASDAQ
  • Current Stock Ticker: PCSA
  1. Context and Measurement:
  • Report Context: The information is as of February 11, 2025.
  • Currency: All monetary values are reported in USD.
  • Units of Measurement: Financial metrics are measured in both USD and shares.
  1. General Notes:
  • The report appears to be a standard filing that includes essential corporate information and may disclose material events impacting the company.
  • The par value of the common stock is notably low, which could indicate a growth-oriented company that may be reinvesting profits rather than distributing dividends.

These elements provide a foundation for understanding the company’s financial standing and corporate activities as of the specified date. Further analysis would require a review of additional financial data and disclosures within the complete report.